Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Mar 2026 for Marinomed Biotech AG, €49k. Read the official filing
Filing timeline
BuySaleSimon Nebel
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Simon Nebel: trading record in brief
This profile gathers the share dealings of Simon Nebel in Marinomed Biotech AG, where the filings describe the role as board member. Over a trading history stretching from 18 September 2024 to 31 March 2026, the count stands at 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €25k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 31 March 2026, reports a transaction of €49k in Marinomed Biotech AG. The latest purchase dates back some time: it was published 757 days ago, on 20 September 2024. Publication is fast: at least half of the trades appear on FMA (OeKB OAM) on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from FMA (OeKB OAM) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Simon Nebel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,521 shares@ €14.000.52% mcap66.1% of flowShareISIN AT0000A3T5H4FMA:247194
3,521 shares@ €14.000.52% mcap66.1% of flowShareISIN AT0000A3T5H4FMA:247192
5,053 shares@ €5.000.27% mcap33.9% of flowShareISIN ATMARINOMED6FMA:204313
Canonical exit: 17 Dec 2024 (T+90)
3 of 3 declarations
